RAC

1.74%

$1.47 race oncology ltd

Hopefully CCSA can lower this risk substantially in our...

First 102 Last

Share
Profile

Follow
Jdmoney

2,083 Posts.

363

14/03/21

16:25

Post #: 51755139
Share

Originally posted by IndexInvestor: ↑

Hi @RaceOncology here's a consolidated memory jogger containing wombat's list and my list, plus some new ones.

Let it not be said that shareholders aren't willing to teach / remind management how to suck eggs (or chickens).
Clinical Trial Execution errors - consolidated post
·paperwork necessary to commence a trial not completed correctly
·wrong indications (could impact recruitment because of competition for patients)
·wrong biomarkers chosen
·patient selection criteria wrong, either inclusion criteria or exclusion criteria
·drug dosing protocol wrong
·endpoints wrong, either primary or secondary
·failure to specify joint primary endpoints when applicable
·wrong selection of blinded vs open label
·trial sites wrong (could impact recruitment)
·clinician recruitment too slow
·patient recruitment too slow
·insufficiently powered for low Type II error. Overly powered is expensive, but penny wise can be pound foolish
·inefficient ratio of sample sizes in treatment arm and control arm. Need good chance of not getting placebo to attract clinicians and patients
·wrong treatment in control arm, e.g. wrong interpretation of Standard of Care
·failure to discuss trial design with regulatory authority
·do discuss trial design with regulatory authority, but fail to follow their hints or advice
·do discuss trial design with regulatory authority, and do follow their hints or advice. Later, when theregulatory authority is assessing the new drug application, the old staff have left and the new staff have different ideas
·leaks from DSMB
·unskilled people running the trial / lab errors.

Expand

Hopefully CCSA can lower this risk substantially in our endeavours to proceed with trials.

https://www.raceoncology.com/race-appoints-clinical-and-fda-regulatory-strategy-advisor/

@RaceOncology there are a plethora of FDA advisory consultants around, was there any reason in particular the board chose CCSA?

RAC Price at posting: $4.00 Sentiment: Hold Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

What each US election outcome would mean for Australian companies & investors

MIN

Movers and Shakers: Zip Co, MinRes, Kuniko, more – The week's top ASX gainers

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Aussie inflation seemingly hit a 3 year low. So why's the ASX200 red?

'We're looking': Nickel-rich Indonesia sounds graphite warning to Aus producers

The Altcoin Landscape (Part 1): Key alternative cryptocurrencies to watch

Week 44 Wrap: Relatively boring week ahead of US election; HotCopper's most watched; Oz inflation at 3.5%

Bitcoin hits fresh record as instos pile into BTC ETFs – and Trump helps, too

Making money: How many microcaps should be in an investor's portfolio?

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

There are more pages in this discussion • 28 more messages in this thread...

First 102 Last

Add RAC (ASX) to my watchlist

(20min delay)
Last $1.47		Change 0.025(1.74%)		Mkt cap ! $249.7M

Open	High	Low	Value	Volume
$1.44	$1.48	$1.44	$25.63K	17.46K

Buyers (Bids)

No.	Vol.	Price($)
1	312	$1.47

Sellers (Offers)

Price($)	Vol.	No.
$1.48	354	1

View Market Depth

No.	Vol.	Price($)
1	312	1.465
1	2000	1.460
1	548	1.440
1	2046	1.420
3	14000	1.410

Price($)	Vol.	No.
1.480	11014	1
1.495	2500	1
1.500	4999	1
1.520	485	1
1.530	10000	1

Last trade - 16.10pm 01/11/2024 (20 minute delay)

RAC (ASX) Chart

Hopefully CCSA can lower this risk substantially in our...

What each US election outcome would mean for Australian companies & investors

Movers and Shakers: Zip Co, MinRes, Kuniko, more – The week's top ASX gainers

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Aussie inflation seemingly hit a 3 year low. So why's the ASX200 red?

'We're looking': Nickel-rich Indonesia sounds graphite warning to Aus producers

The Altcoin Landscape (Part 1): Key alternative cryptocurrencies to watch

Week 44 Wrap: Relatively boring week ahead of US election; HotCopper's most watched; Oz inflation at 3.5%

Bitcoin hits fresh record as instos pile into BTC ETFs – and Trump helps, too

Making money: How many microcaps should be in an investor's portfolio?

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Hopefully CCSA can lower this risk substantially in our...

Top Stories

What each US election outcome would mean for Australian companies & investors

Movers and Shakers: Zip Co, MinRes, Kuniko, more – The week's top ASX gainers

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Aussie inflation seemingly hit a 3 year low. So why's the ASX200 red?

'We're looking': Nickel-rich Indonesia sounds graphite warning to Aus producers

The Altcoin Landscape (Part 1): Key alternative cryptocurrencies to watch

Week 44 Wrap: Relatively boring week ahead of US election; HotCopper's most watched; Oz inflation at 3.5%

Bitcoin hits fresh record as instos pile into BTC ETFs – and Trump helps, too

Making money: How many microcaps should be in an investor's portfolio?

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News